About DILOXANIDE FUROATE IP/BP/EP/USP
Diloxanide furoate is an antiprotozoal medication used primarily in the treatment of non-invasive intestinal amoebiasis caused by Entamoeba histolytica. It is effective against the cyst form of the parasite that causes amoebic infections. This medication works locally in the intestine to eradicate the amoeba, helping to alleviate symptoms and prevent complications associated with amoebiasis.
Reliable Quality and ComplianceDiloxanide Furoate is manufactured adhering to the most rigorous quality standards, complying with IP/BP/EP/USP specifications. With a minimum 99% assay and impurity levels strictly controlled, it ensures optimal performance and patient safety. Additionally, it passes all standard identification, microbial, and physical property tests, providing peace of mind for pharmaceutical formulators.
Versatile Pharmaceutical ApplicationsThis API is primarily used as an anti-amoebic agent, effectively treating intestinal and hepatic amoebiasis. Its high purity and consistent particle size result in reliable blending and formulation for both tablet and suspension forms. As a raw material, it also suits various research and development needs within the pharmaceutical industry.
Packaging and Stable StorageAvailable in robust 25 kg fiber drums or customized packaging, Diloxanide Furoate ensures safe handling and prolonged shelf life. It maintains its properties for up to five years when stored in cool, dry conditions, protected from light, thus guaranteeing continual quality from manufacturer to end user.
FAQ's of DILOXANIDE FUROATE IP/BP/EP/USP:
Q: How is Diloxanide Furoate IP/BP/EP/USP typically used in pharmaceutical formulations?
A: Diloxanide Furoate IP/BP/EP/USP is primarily formulated into anti-amoebic medications, effectively used for treating both intestinal and hepatic amoebiasis. It can be incorporated into various oral dosage forms such as tablets or suspensions due to its high purity and stable physicochemical properties.
Q: What are the storage recommendations and shelf life for this product?
A: The API should be stored in a cool, dry place, shielded from light, to retain its integrity. When properly stored, Diloxanide Furoate maintains a shelf life of five years from the date of manufacture, ensuring long-term stability for pharmaceutical production.
Q: Where is Diloxanide Furoate IP/BP/EP/USP manufactured and can custom packaging be arranged?
A: This API is manufactured in India by reputable producers and is supplied in standard 25 kg fiber drums. Custom packaging options are also available to accommodate specific client needs and logistic requirements.
Q: What standards does Diloxanide Furoate IP/BP/EP/USP meet regarding purity and impurities?
A: The product boasts a purity of not less than 99% (on dried basis), with assay limits between 99.0% and 101.0%. Total impurities do not exceed 1.0%, while moisture, residue on ignition, and loss on drying are all strictly controlled as per relevant pharmacopeias (IP, BP, EP, USP).
Q: What benefits does Diloxanide Furoate offer to pharmaceutical manufacturers?
A: Pharmaceutical manufacturers benefit from its high purity, reliable compliance with global pharmacopoeial standards, and excellent stability. Its consistent particle size and robust packaging facilitate straightforward formulation and handling, supporting the production of effective anti-amoebic medications.
Q: How does the solubility profile of Diloxanide Furoate influence its formulation process?
A: Diloxanide Furoate is slightly soluble in water but readily soluble in methanol and chloroform, making it suitable for a range of formulation techniques. This allows for flexible extraction and blending processes tailored to the intended dosage form.